Linda Feagins
Interim Chief · University of Texas at Austin Dell Medical School
Credentials: · · · ·
History
- Present
Center for Inflammatory Bowel Diseases · University of Texas at Austin Dell Medical School
- 1997–2001
Research
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer
Review · Nature Reviews Gastroenterology & Hepatology · 2009 · First of 3 authors · Corresponding · 239 citations
Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease
Digestive Diseases and Sciences · 2015 · Last of 4 authors · 157 citations
Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
PLoS ONE · 2016 · 150 citations
25 papers
12 papers
- JH
8 papers
8 papers
6 papers
6 papers
- RW
6 papers
5 papers
Grants
- 2014–2019
Risk of Post-Polypectomy Bleeding with Prophylactic Hemoclipping
Department of Veterans Affairs · I01
Contact PI · Va North Texas Health Care System
Clinical trials
- 2024–2025
Beta-Hydroxybutyrate Feasibility Treating IBD
Principal investigator · Recruiting · Phase 1, Phase 2
University of Texas at Austin
- 2011–2018
Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping
Principal investigator · Completed
VA Office of Research and Development
- 2009–2012
Exacerbating Factors in Inflammatory Bowel Disease
Principal investigator · Completed
Dallas VA Medical Center